• Explore /
  • Poster
  • / Randomized phase II study of the x-linked inhibitor of apoptosis (XIAP) antisense AEG35156 in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC).

Randomized phase II study of the x-linked inhibitor of apoptosis (XIAP) antisense AEG35156 in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC).

Abstract Poster

Authors

Ann Shing Lee

Ann Sing Lee

Tuen Mun Hospital, Tuen Mun, Hong Kong

Ann Sing Lee , Benny C.Y. Zee , Foon Yiu Cheung , Philip Kwong , Ashley Chi Kin Cheng , Maria Lai , Chloe Kwok , Marc Chong , Jacques Jolivet , C L Chiang , K C Leung , Steven Siu , Conrad Lee , Stewart Yuk Tung

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Clinical Trial Registration Number

NCT00882869

Citation

J Clin Oncol 30, 2012 (suppl; abstr 4105)

DOI

10.1200/jco.2012.30.15_suppl.4105

Abstract #

4105

Poster Bd #

48H

Abstract Disclosures

Similar Posters

First Author: Mingyue Cai

First Author: Choong-kun Lee

First Author: Jorg Trojan

First Author: Sukeshi Patel Arora